I create Thinking Partnerships with leaders to improve performance

David is Co-CEO of fassforward Consulting Group. He partners with clients to improve their leadership, culture, productivity, and life/work balance. He leads fassforward's Executive Coaching practice, oversees finance and is focused on developing FCG’s biggest asset, its people and culture.

Prior to joining the fassforward, David spent 20 years on Wall Street. He worked at Morgan Stanley for 9 years in Institutional Equity Derivatives where he managed Hedge Fund Sales Trading. David was also a leader in the firm’s recruiting program, taught in the training program, and was a significant contributor in the growth of the firm’s derivative platform for hedge fund clients. In 2008, David joined New Mountain Capital to launch a risk management strategy and start a trading desk for the firm’s hedge fund with assets of approximately $1 billion. In 2010, he was promoted to Portfolio Manager, co-managing the hedge fund, which had grown to over $2 billion in assets. 
Through his work at fassforward, his yoga studio and his charity, David has enjoyed being focused on "doing good things for good people". David received his A.B., magna cum laude from Princeton University.

David Frost

Senior Director, Strategic Planning, Biostatistical Consulting Services at ICON PLC

I help organizations maximize the value of their sponsor-CRO partnerships, whether responding to commercial or federal RFPs, navigating CRO selection, or optimizing delivery strategies.

With 20 years leading proposals, delivery strategy, and contracts for global CROs, plus sponsor-side resource forecasting and vendor governance experience, I've delivered complex agreements valued from $1.5M to $300M+ across pharma, emerging biotech, and federal (NIH, NIAID, BARDA, DoD) sectors in oncology, rare disease, cell & gene therapy, infectious disease, cardiovascular, metabolic, CNS, reproductive health, and inflammation.

Leading the full lifecycle of clinical research proposals and contracts: RFx strategy and response, SOW and pricing model development, Master Service Agreement and change order negotiation, and vendor governance, I bridge sponsor needs and delivery capabilities, whether a federal health research contract, an emerging biotech Phase 1 or 2 study, a pharma Phase 3/3b trial, a regulatory application, a RWE study, or FSP engagement.

Combining strategic thinking with operational discipline, I consistently deliver measurable results: 70% reduction in budget cycle times, 10%-25% reduction in uncompensated delivery per project through budget accuracy, scope and change order management. I also build Excel-based pricing models bringing transparency to complex pricing, perform scenario modeling and sensitivity analyses to ensure cost-effectiveness and margin protection, offer sponsor-side experience managing vendor resource forecasting and governance, and facilitate Red Team exercises that stress-test assumptions and strategies.

RFx Strategy & Response | Proposals | Contracts & Change Orders | Full-Service & FSP | Phase 1-4 Clinical Trials | Federal Health Contracting (NIH, BARDA, DoD) | FAR-Compliant Cost Proposals | Inactive Secret Clearance | CRO Pricing & Delivery Strategy | Master Service Agreement Negotiation | Win Strategy & Competitive Intelligence | Excel-Based Financial Modeling | Scenario Planning & Analysis | Certified Red Team Instructor | Cross-Functional Leadership (BD, Ops, Finance, Legal) | Vendor Governance | GCP-ICH Compliance | Coach & Mentor | Notary Public

#OpenToWork Seeking senior IC and director-level opportunities leading proposal and contracts functions, building teams, or creating strategic value in sponsor-CRO partnerships. Reach out if you're hiring for CRO proposals and contracts, clinical outsourcing, federal health contracting, or BD roles.

taplio

The Battle

David Frost

Kathleen Ferguson

Followers

Posts

Engagements

Likes

Ready to grow your LinkedIn presence?